INTRODUCTION
A choledochal cyst is a rare benign disease of the biliary tract. 1 Almost 80% of cases are diagnosed in the first decade of life, and this disease is four times more common in women. This disease is also known to be more prevalent in Asian countries. [2] [3] [4] The choledochal cyst was first described by Vater and Ezler in 1723 and classified by Todani in 1977 in accordance with its anatomical location and morphology. 5 Although choledochal cysts are classified as benign, malignant transformation, cholangitis, pancreatitis and other complications may occur if they are not treated. 6 Surgical resection is the standard treatment method because a malignant transformation rate of 10-30% is possible. [7] [8] [9] [10] The standard surgical procedure is a complete excision of the cyst with Roux-en-Y hepaticojejunostomy anastomosis and laparoscopic surgery has been increasingly used since it was first described by Farello et al. 11 in 1995. This is still a challenging way to perform a hepaticojejunostomy due to the small diameter of the bile duct and the possibility of bile leak or stricture.
As robotic surgery has continued to develop, it has become possible to perform complex minimal access proce-dures using these systems. Robotic surgical systems can overcome the shortcomings of laparoscopic surgery. By providing a three-dimensional view, magnification of the area in question, articulated instrumentation and an increased freedom of movement of the surgical instruments. 12, 13 Moreover, robotic systems are ergonomically better for the surgeon. Also, since choledochal cysts are common in young women, 14, 15 the improved cosmetic outcomes when using robotic equipment are desirable and have led to these surgeries becoming more widespread to treat this disease.
Despite many reports on robotic procedures for hepatectomy and pancreatic surgery, there have not been many previous studies of the use of robotic-assisted excision for choledochal cysts in adults. We have used laparoscopic surgery at our institute since 2009 to treat these cysts but started to perform robotic surgery for these cases from January 2014. The aims of our current study were to evaluate the safety and feasibility of using robotic procedures to treat a choledochal cyst, and to compare the robotic approach with our early and late experiences with the laparoscopic procedure.
MATERIALS AND METHODS

Patient selection
We try in principle at our institute to apply a minimally invasive approach to treating a choledochal cyst if there is no suspicion of biliary tract malignancy. We here performed a retrospective analysis of adult patients (≥18 years) who underwent a robotic and laparoscopic procedure for cyst excision and Roux-en-Y hepaticojejunostomy at our hospital, Asan Medical center, Seoul, Korea, between January 2014 and December 2017. We received appropriate informed consent from all patients and we received IRB approval.
We previously reported in 2012 our initial experiences with the laparoscopic approach to treating a choledochal cyst in adults. 16 Since that time, a large number of lapa- 
Robotic surgical technique
The surgical techniques used at out hospital for choledochal cyst excision are similar between the robotic and laparoscopic approaches, and our laparoscopic procedure has been fully described in a previous report that described early experience of laparoscopic surgery for choledochal cyst. 16 Briefly, the patients were placed in a re- Fig. 2A) . The distal portion of the cyst was safely ligated and divided using hemo-loc or endo-stapler (Fig. 2B) . Using the distal stump of the cyst as a retractor, further upward dissection was performed until the hepatic ducts were sufficiently observed with identification of the right hepatic artery and main portal vein. The bile duct was then transected just below the hilum and the cyst and gallbladder were placed into a LapBag (Sejong Co., Paju, Korea). After dedocking, the specimen including the bile duct and gallbladder, was removed through extension of the periumbilical port site (about 2.5-3 cm). The jejunum at 40 cm distal to the Trieitz ligament was then exteriorized through the periumbilical port site and was divided using an EndoGIA linear stapler.
Jejunojejunostomy anastomosis was performed extracorporeally by manual suturing or an EndoGIA stapler.
The da Vinci system continued to be used after the bowel was repositioned into the peritoneal cavity. A hepaticojejunostomy was performed intracorporeally using a needle holder on robotic arms 1 and 2 ( findings, the patients were followed up every 6 or 12 months at the discretion of the surgeon. In this study, the overall follow-up period ranged from 5 months to a maximum of 100 months.
Statistic analysis
The Kolmogorov-Smirnov and Shapiro-Wilk tests were used to test the normality of the data in the three groups.
One way ANOVA was applied to compare the differences between the three groups for factors that satisfy the normality. And the post-hoc analysis was perfomed As shown in Table 1 , more than 64% of the patients had AUPBD in all groups.
RESULTS
Clinical characteristics of patients
To prevent pancreatitis or pancreatic duct injury after surgery, the number of patients with a preoperative insertion of ERPD was 5 in Group 1 and 2 in Group 2 and none in Group 3.
Postoperatively, biopsy specimens showing GB cancer (stage I, pT1NxM0) were found only in the robotic group with no malignancies observed in the other groups.
Clinical findings
The mean operative time were 258.5±52.9 min for robotic surgery (Group 1), 236.2±62.9 min for late laparoscopic surgery (Group 2), and 395.2±85.9 min for the initial laparoscopic surgery group (Group 3).
In all cases, a hepaticojejunostomy was performed intracorporeally. A jejunojejunostomy was performed intracorporeally in 11 of 13 cases and extracorporeally in only 2 cases in the initial laparoscopic surgery (Group 3).
However, for the procedures undertaken at out hospital over the last 4 years, extracorporeal anastomosis was performed in all cases in Group 1 and all but one case in Group 2.
The anterior wall suturing of hepaticojejunostomy was performed more interrupted suture than continuous suture in three groups, respectively. On the other hand, the posterior wall suturing was performed more continuous suture than interrupt suture in all groups.
The median hospital stay was 7 days for both Group (Table 2) .
Postoperative complications Postoperative complications occurred in three patients
who underwent robotic surgery (Group 1). This included a case of cholangitis which was resolved after conservative treatment, and bile leakage which was treated The early laparoscopic surgery patients (Group 3) had complications in 3 cases. A hepaticojejunostomy site stricture occurred in 2 patients and a revision operation and biliary stent insertion were performed. Paralytic ileus was also observed in one case and these symptoms improved after conservative care. There were no mortality case in any of the three groups.
DISCUSSION
A choledochal cyst is a rare disease that is usually found in children and is often observed in young women when diagnosed in adults. 5 The symptoms of this disease manifest as abdominal pain, a right upper quadrant mass and obstructive jaundice in the pediatric population, and abdominal pain and biliary or pancreatic symptoms in adults. 4 Although this disease is typically benign, surgical treatment should be considered as a priority because there is a low probability of malignancy. Long-term follow-up is therefore also needed after surgery. 17 Laparoscopic surgery to treat a choledochal cyst was first described by Farello et al. Initially, an intracorporeal jejunojejunostomy was performed in 11 out of 13 cases at our center and a total laparoscopic procedure without manual procedures was conducted in most cases. In our more recent laparoscopic surgeries for a choledochal cyst, extracorporeal jejunojejunostomy was performed in 33 out of 34 cases, which dramatically reduced the operation time from 395.2±85.9 minutes to 236.2±62.9 minutes [p=0.000]. Table 3 Also, when the learning curve is taken into consideration, our initial series of robotic surgery patients have shown quite favorable results. We can expect that the operation times will be shortened for the robotic procedures in our hospital as more experience is gained with these surgeries.
This study had some limitations of note. First, it was retrospective investigation with inherent biases. Notably however, a large prospective study is not easy for diseases such as a choledochal cyst which are rare. Second, the number of robotic cases was relatively small. However, this was an initial series however and we would point to the fact that we have to our knowledge described the largest number of robotic cases in biliary and pancreatic surgery such as pancreaticoduodenectomy. Future multicenter studies with large patient populations and longer-term follow-ups are warranted to further evaluate the safety and feasibility of robotic surgery. Currently, robotic procedure is considerably more expensive than laparoscopic procedure. So cost-effectiveness of using a robotic system also should be evaluated.
A robot-assisted resection of a choledochal cyst with a Roux-en-y hepaticojejunostomy is a safe and feasible option with short-term results that are comparable to laparoscopic surgery. Compared to laparoscopic surgery, robot-assisted techniques also have distinct advantages such as better intracorporeal suturing and provision of a good 3D visual field.
It is likely that robotic surgery will soon become more widely adopted to complement the current limitations of conventional laparoscopic surgery.
